Rhode Island General Laws
Chapter 27-20 - Nonprofit Medical Service Corporations
Section 27-20-37. - Drug coverage.

§ 27-20-37. Drug coverage.
(a) Any nonprofit medical-service corporation that utilizes a formulary of medications for which coverage is provided under an individual or group plan master contract shall require any physician or other person authorized by the department of health to prescribe medication to prescribe from the formulary. A physician or other person authorized by the department of health to prescribe medication shall be allowed to prescribe medications previously on, or not on, the nonprofit medical-service corporation’s formulary if he or she believes that the prescription of the non-formulary medication is medically necessary. A nonprofit medical-service corporation shall be required to provide coverage for a non-formulary medication only when the non-formulary medication meets the nonprofit medical-service corporation’s medical-exception criteria for the coverage of that medication.
(b) A nonprofit medical-service corporation’s medical-exception criteria for the coverage of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3) [repealed].
(c) Any subscriber who is aggrieved by a denial of benefits to be provided under this section may appeal the denial in accordance with the rules and regulations promulgated by the department of health pursuant to chapter 17.12 of title 23 [repealed].
(d) Prior to removing a prescription drug from its plan’s formulary or making any change in the preferred or tiered, cost-sharing status of a covered prescription drug, a nonprofit medical-service corporation must provide at least thirty (30) days’ notice to authorized prescribers by established communication methods of policy and program updates and by updating available references on web-based publications. All adversely affected members must be provided at least thirty (30) days’ notice prior to the date such change becomes effective by a direct notification:
(i) The written or electronic notice must contain the following information:
(A) The name of the affected prescription drug;
(B) Whether the plan is removing the prescription drug from the formulary, or changing its preferred or tiered, cost-sharing status; and
(C) The means by which subscribers may obtain a coverage determination or medical exception, in the case of drugs that will require prior authorization or are formulary exclusions respectively.
(ii) A nonprofit medical-service corporation may immediately remove from its plan formularies covered prescription drugs deemed unsafe by the nonprofit medical-service corporation or the Food and Drug Administration, or removed from the market by their manufacturer, without meeting the requirements of this section.
History of Section.P.L. 1998, ch. 290, § 3; P.L. 2016, ch. 541, § 3; P.L. 2017, ch. 274, § 3; P.L. 2017, ch. 361, § 3.

Structure Rhode Island General Laws

Rhode Island General Laws

Title 27 - Insurance

Chapter 27-20 - Nonprofit Medical Service Corporations

Section 27-20-1. - Definitions.

Section 27-20-1.1. - Applicability.

Section 27-20-2. - Organization as charitable corporation — Insurance laws inapplicable.

Section 27-20-3. - Qualifications of directors.

Section 27-20-4. - Approval of articles of association.

Section 27-20-5. - Contracts with subscribers.

Section 27-20-5.1. - Cancellation of coverage by employers.

Section 27-20-5.2. - Repealed.

Section 27-20-5.3. - Patient responsibility — Administrative requirements.

Section 27-20-6. - Rates charged subscribers — Reserves — Hearing by commissioner. [Effective until January 1, 2023.]

Section 27-20-6.1. - Uniform explanation of benefits and coverage.

Section 27-20-6.2. - Filing of policy forms.

Section 27-20-7. - Relationship of physician and patient — Actions against corporation.

Section 27-20-8. - Annual and quarterly statements.

Section 27-20-9. - Examination of affairs of corporation.

Section 27-20-10. - Commission plans for solicitors or insurance producers.

Section 27-20-11. - Investment standards.

Section 27-20-12. - Corporation deemed public charitable institution.

Section 27-20-13. - Adoption of chapter by hospital service corporation.

Section 27-20-14. - Coverage for adoptive children.

Section 27-20-15. - Itemized bills for services rendered.

Section 27-20-16. - Changing coverage.

Section 27-20-17. - Mammograms and pap smears — Coverage mandated.

Section 27-20-17.1. - Insurance coverage for post-partum hospital stays.

Section 27-20-18. - Mammograms — Quality assurance standards.

Section 27-20-19. - Pap smears — Quality assurance standards.

Section 27-20-20. - Coverage for infertility.

Section 27-20-21. - Nonprofit medical service corporation assessment.

Section 27-20-22. - Discontinuance of coverage — Chronic disabilities.

Section 27-20-23. - Drug coverage.

Section 27-20-23.1. - Medication synchronization.

Section 27-20-23.2. - Pharmacy benefit manager requirements with respect to multi-source generic pricing updates to pharmacies.

Section 27-20-24. - Rehabilitation, liquidation, or conservation.

Section 27-20-25. - Holding company systems.

Section 27-20-25.1. - No derogation of attorney general.

Section 27-20-25.2. - Health insurance rates.

Section 27-20-26. - Regulations.

Section 27-20-27. - New cancer therapies — Under investigation. [Repealed on effective date of § 27-20-64.]

Section 27-20-27.1. - “Reliable evidence” defined. [Repealed on effective date of § 27-20-64.]

Section 27-20-27.2. - Conditions of coverage. [Repealed on effective date of § 27-20-64.]

Section 27-20-27.3. - Managed care. [Repealed on effective date of § 27-20-64.]

Section 27-20-28. - Repealed.

Section 27-20-29. - Mastectomy treatment.

Section 27-20-29.1. - Insurance coverage for mastectomy hospital stays.

Section 27-20-30. - Diabetes treatment.

Section 27-20-31. - Primary and preventive obstetric and gynecological care.

Section 27-20-31.1. - Hysterectomy or myomectomy treatment.

Section 27-20-32. - Whistleblowers protection.

Section 27-20-33. - Penalties and remedies.

Section 27-20-34. - Additional relief and damages — Reinstatement.

Section 27-20-35. - Third-party reimbursement for services of certain healthcare workers.

Section 27-20-35.1. - Third party reimbursement for services of registered nurse first assistants.

Section 27-20-36. - Human leukocyte antigen testing.

Section 27-20-37. - Drug coverage.

Section 27-20-38. - Restricted annual rate payments prohibited.

Section 27-20-39. - Genetic testing.

Section 27-20-39.1. - Genetic information.

Section 27-20-40. - Repealed.

Section 27-20-41. - Magnetic resonance imaging — Quality assurance standards.

Section 27-20-42. - Acupuncture services.

Section 27-20-43. - F.D.A. approved prescription contraceptive drugs and devices.

Section 27-20-44. - Prostate and colorectal examinations — Coverage mandated — The Maryellen Goodwin Colorectal Cancer Screening Act.

Section 27-20-45. - Eligibility for children’s benefits.

Section 27-20-46. - Hearing aids.

Section 27-20-47. - Prompt processing of claims.

Section 27-20-48. - Mandatory coverage for certain lyme disease treatments.

Section 27-20-49. - Dental insurance assignment of benefits.

Section 27-20-50. - Coverage for early intervention services.

Section 27-20-51. - Post-payment audits.

Section 27-20-52. - Reimbursement for orthotics and prosthetic services.

Section 27-20-53. - Tobacco cessation programs.

Section 27-20-54. - Mandatory coverage for scalp hair prosthesis.

Section 27-20-55. - Licensed ambulance service.

Section 27-20-56. - Enteral nutrition products.

Section 27-20-57. - Prohibition on preexisting condition exclusions.

Section 27-20-58. - Prohibition on rescission of coverage.

Section 27-20-59. - Annual and lifetime limits.

Section 27-20-60. - Coverage for individuals participating in approved clinical trials.

Section 27-20-61. - Medical loss ratio reporting and rebates.

Section 27-20-62. - Emergency services.

Section 27-20-63. - Internal and external appeal of adverse benefit determinations.

Section 27-20-64. - Reserved.

Section 27-20-65. - Primary care provider designation requirement.

Section 27-20-66. - Discretionary clauses.

Section 27-20-67. - Orally administered anticancer medication — Cost-sharing requirement.

Section 27-20-68. - Consumer notification.

Section 27-20-69. - Opioid antagonists.

Section 27-20-70. - Healthcare provider credentialing.

Section 27-20-71. - Unfair discrimination prohibited.

Section 27-20-72. - Health insurance contracts — Full year coverage for contraception.

Section 27-20-73. - Prohibition on discrimination in organ transplants.

Section 27-20-74. - Health insurance contracts — Copayments exemption for COVID-19 vaccinations.

Section 27-20-75. - Perinatal doulas.

Section 27-20-76. - Gender rating. [Effective January 1, 2023.]

Section 27-20-77. - Coverage for biomarker testing.

Section 27-20-78. - Mandatory coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome. [Expires December 31, 2025.]